4//SEC Filing
Letendre Peter 4
Accession 0001181431-12-046593
CIK 0000849636other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:05 PM ET
Size
4.8 KB
Accession
0001181431-12-046593
Insider Transaction Report
Form 4
Letendre Peter
Director
Transactions
- Award
Common Stock
2012-08-10+684,031→ 684,031 total
Footnotes (1)
- [F1]Received in exchange for options to purchase 188,000 shares of Pier Pharmaceuticals, Inc. common stock and the right to receive $30,000 of cash consideration, all in connection with the merger among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. (a wholly-owned subsidiary of Cortex Pharmaceuticals, Inc.) and Pier Pharmaceuticals, Inc. (the "Merger"). On the effective date of the Merger, the closing price of the common stock of Cortex Pharmaceuticals, Inc. was $0.06 per share.
Documents
Issuer
CORTEX PHARMACEUTICALS INC/DE/
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001361947
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 4:05 PM ET
- Size
- 4.8 KB